What people need to understand last year after merger with sgp Mrk went thru the pipeline and made cuts on what they were Not going go advance With rids meeting it's endpoints and now that it's in mrk report there Should be no talk of mrk not being on board with rida
Keep an eye on clinicaltrials. As this is were I expect you will see othr Trials come on board
Yep, they could have put most anything in those business highlights....but they chose little ole Rida.
I want to know why we arent trading at $8. Hell for that matter DNDN doesnt offer any great drugs and look at that thing. I guess we are just here "on the ground floor" and I will happy with that for now.